Merck & Co., Inc. (MRK)

USD 83.18

(-0.1%)

Total Liabilities Summary of Merck & Co., Inc.

  • Merck & Co., Inc.'s latest annual total liabilities in 2023 was 69.04 Billion USD , up 9.41% from previous year.
  • Merck & Co., Inc.'s latest quarterly total liabilities in 2024 Q2 was 68.98 Billion USD , up 5.44% from previous quarter.
  • Merck & Co., Inc. reported annual total liabilities of 63.1 Billion USD in 2022, down -6.43% from previous year.
  • Merck & Co., Inc. reported annual total liabilities of 67.43 Billion USD in 2021, up 1.89% from previous year.
  • Merck & Co., Inc. reported quarterly total liabilities of 68.98 Billion USD for 2024 Q2, up 5.44% from previous quarter.
  • Merck & Co., Inc. reported quarterly total liabilities of 60.89 Billion USD for 2023 Q1, down -3.5% from previous quarter.

Annual Total Liabilities Chart of Merck & Co., Inc. (2023 - 1989)

Historical Annual Total Liabilities of Merck & Co., Inc. (2023 - 1989)

Year Total Liabilities Total Liabilities Growth
2023 69.04 Billion USD 9.41%
2022 63.1 Billion USD -6.43%
2021 67.43 Billion USD 1.89%
2020 66.18 Billion USD 13.34%
2019 58.39 Billion USD 4.74%
2018 55.75 Billion USD 4.6%
2017 53.3 Billion USD -3.21%
2016 55.06 Billion USD -3.41%
2015 57.01 Billion USD 15.07%
2014 49.54 Billion USD -7.08%
2013 53.31 Billion USD 5.23%
2012 50.66 Billion USD 5.16%
2011 48.18 Billion USD -1.62%
2010 48.97 Billion USD -3.2%
2009 50.59 Billion USD 94.39%
2008 26.02 Billion USD -6.23%
2007 27.75 Billion USD 12.82%
2006 24.6 Billion USD 0.33%
2005 24.52 Billion USD 7.19%
2004 22.87 Billion USD 8.45%
2003 21.09 Billion USD -13.66%
2002 24.43 Billion USD 5.68%
2001 23.11 Billion USD 15.27%
2000 20.05 Billion USD 5.94%
1999 18.93 Billion USD 23.37%
1998 15.34 Billion USD 27.74%
1997 12.01 Billion USD 19.99%
1996 10.01 Billion USD 2.07%
1995 9.8 Billion USD 3.17%
1994 9.5 Billion USD 8.53%
1993 8.76 Billion USD 60.58%
1992 5.45 Billion USD 36.82%
1991 3.98 Billion USD 9.37%
1990 3.64 Billion USD 33.74%
1989 2.72 Billion USD -16.67%

Peer Total Liabilities Comparison of Merck & Co., Inc.

Name Total Liabilities Total Liabilities Difference
AbbVie Inc. 124.31 Billion USD 44.463%
Bristol-Myers Squibb Company 65.67 Billion USD -5.125%
Bristol-Myers Squibb Company Ce 65.67 Billion USD -5.125%
Johnson & Johnson 98.78 Billion USD 30.11%
Eli Lilly and Company 53.14 Billion USD -29.915%
Novartis AG 53.19 Billion USD -29.787%
Organon & Co. 12.12 Billion USD -469.261%
Pfizer Inc. 137.21 Billion USD 49.684%